Drug
Intepirdine clinical trials
Also written SB-742457.
- studies test it
- 10
- open now
- 0
- in phase 3
- 3
- first study started
- 2005
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2016 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2015 | 1 |
| 2016 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Axovant Sciences Ltd. (5) · GlaxoSmithKline (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses intepirdine is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaCompletedPhase 2Axovant Sciences Ltd.NCT02910102Written as RVT-101 35 mg
- 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET ExtensionTerminatedPhase 3Axovant Sciences Ltd.NCT02586909Written as RVT-101 35 mg tablets
- Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB StudyCompletedPhase 2Axovant Sciences Ltd.NCT02669433Written as RVT-101 35 mg
- Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyCompletedPhase 3Axovant Sciences Ltd.NCT02585934Written as RVT-101
- Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's DiseaseCompletedPhase 2GlaxoSmithKlineNCT00708552Written as SB-742457
- Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB ExtensionTerminatedPhase 2/3Axovant Sciences Ltd.NCT02928445Written as RVT-101 35 mg
- A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseCompletedPhase 2GlaxoSmithKlineNCT00710684Written as SB-742457 15mg
- A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's DiseaseCompletedPhase 2GlaxoSmithKlineNCT00224497Written as SB-742457
- SB-742457 And Donepezil In Alzheimer's DiseaseCompletedPhase 2GlaxoSmithKlineNCT00348192Written as SB-742457
- A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.CompletedPhase 1GlaxoSmithKlineNCT00551772Written as SB-742457
Codes
What other systems call intepirdine · ClinicalTrials.gg INT005593
- UNII (FDA) 2IOB2M82HYINTEPIRDINEConfirmed FDA, Wikidata
- Wikidata Q855449intepirdineConfirmed FDA, Wikidata
- NCI Thesaurus C166572IntepirdineOne source FDA
- DrugBank DB12680One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2IOB2M82HY | INTEPIRDINE | Confirmed FDA, Wikidata |
| Wikidata | Q855449 | intepirdine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166572 | Intepirdine | One source FDA |
| DrugBank | DB12680 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.